1/1
3 files

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

media
posted on 23.03.2020 by Christian Zurth, Mikko Koskinen, Robert Fricke, Olaf Prien, Timo Korjamo, Kristina Graudenz, Karsten Denner, Michaela Bairlein, Clemens-Jeremias von Bühler, Gary Wilkinson, Hille Gieschen

The above video abstract, slide deck and script represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

Funding

This trial was supported by Orion Corporation, Orion Pharma and Bayer AG.

History

Exports

Logo branding

Categories

Exports